Haiyan Li

发表

Cost-Effectiveness of Edoxaban vs. Warfarin in Patients with Atrial Fibrillation Based on Results of the ENGAGE AF - TIMI 48 Trial: Taiwanese Perspective.

R. Giugliano, D. Cohen, E. Magnuson, 2017, Value in health regional issues.

Cost-Effectiveness of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons Versus Standard Percutaneous Transluminal Angioplasty: Results From the IN.PACT SFA II Trial.

M. Jaff, D. Cohen, J. Laird, 2016, JACC. Cardiovascular interventions.

Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial

E. Antman, R. Giugliano, E. Braunwald, 2020, Circulation. Cardiovascular quality and outcomes.

Long‐term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3‐year results from the STROLL study

W. Gray, M. Jaff, D. Cohen, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective

D. van Klaveren, E. Steyerberg, P. Serruys, 2015, Heart.

Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

P. Serruys, F. Mohr, M. Morice, 2014, Circulation.

Cost-Effectiveness of Percutaneous Coronary Intervention with Drug-Eluting Stents vs. Bypass Surgery for Patients with 3-Vessel or Left Main Coronary Artery Disease: Final Results from the SYNTAX Trial

P. Serruys, F. Mohr, M. Morice, 2014 .

Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

E. Antman, R. Giugliano, D. Cohen, 2017, Journal of the American Heart Association.

Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).

M. Mack, J. Bavaria, L. Svensson, 2012, Journal of the American College of Cardiology.

Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial.

Marc P. Bonaca, Deepak L. Bhatt, M. Sabatine, 2017, Journal of the American College of Cardiology.

Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at Standard Surgical Risk: Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)

W. Gray, T. Brott, Jenifer Voeks, 2012, Stroke.

, Versus Stenting Trial ( CREST ) Standard Surgical Risk : Results From the Carotid Revascularization Endarterectomy Costs and Cost-Effectiveness of Carotid Stenting Versus Endarterectomy for Patients at

W. Gray, T. Brott, Jenifer Voeks, 2012 .

Cost-Effectiveness of Percutaneous Coronary Intervention With Drug Eluting Stents Versus Bypass Surgery for Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease: Results From the FREEDOM Trial

Lynn A. Sleeper, David J. Cohen, Valentin Fuster, 2013, Circulation.

D. Cohen, E. Armstrong, E. Magnuson, 2021, Journal of medical economics.

In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty: Insights From the OPEN-CTO Registry.

J. Spertus, J. Moses, S. Arnold, 2019, JACC. Cardiovascular interventions.

Economic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: One‐year results from the SYNTAX trial

Duane Pinto, P. Serruys, F. Mohr, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study

Neel M. Butala, D. Wood, J. Cairns, 2022, Circulation. Cardiovascular interventions.

Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial.

E. Antman, R. Giugliano, D. Cohen, 2015, American heart journal.

Abstract 16534: Cost-Effectiveness of Edoxaban vs. Warfarin in Patients With Atrial Fibrillation: Results From the ENGAGE AF - TIMI 48 Economic Study

E. Antman, E. Magnuson, C. Ruff, 2014 .

V. Fuster, L. Sleeper, M. Farkouh, 2013, Circulation.